Regulatory/GMP Compliance, Emerging Markets

Report from India

November 02, 2010

IP rights and levels of innovation have opened a bit of controversy regarding decisions being made by Indian courts and legislators.

Report from Brazil September 2010

September 02, 2010

A look at why Brazil revised its GMP standards and how the changes will affect the local pharmaceutical industry.

Outsourcing: The Indian Perspective

September 01, 2010

Pharmaceutical Technology Europe

India has evolved from a low-cost region to an area with extensive technical capability and high quality standards.

Report from Asia

August 02, 2010

Manufacturers and regulators on both sides of the ocean move to ensure the safety of heparin and other globally distributed drug products.

Report from India

July 02, 2010

As generic divisions become the most-wanted acquisitions of Big Pharma, India's domestic industry may be thinning out.

Report from Brazil May 2010

May 02, 2010

The growth of Brazil's generic-drug market is on a fast track, but what are the projections for the sector's future?

Report from Asia

April 02, 2010

As demand for global vaccine development and production grows, all eyes are turning to Asia.

Report from India

March 02, 2010

Could President Obama's tax reform, which is targeted at reducing outsourcing, endanger India's contract-services industry?

Report from: the Philippines

November 02, 2009

New pricing controls and healthcare reforms may be pushing the pharmaceutical market out of this southeast Asian country. This article contains bonus online-exclusive material.

Report From: India

October 02, 2009

Pharmaceutical companies in India have had a hold on the biotechnology sector for many years, and they're not about to let the follow-on biologics market pass them by.